These data, combined with our previous finding showing that EZH2 is augmented in human compensated right ventricle (RV) but markedly decreased in decompensated RV from PAH patients [16], indicate that altered expression of EZH2 in PAH appears to be mainly restricted to the cardiopulmonary system. Here, EZH2 is linked to pulmonary arterial hypertension.